VP Asset Lead - Oncology P3 Strategy & Commercialization

Tyra Biosciences, Inc. is seeking a highly motivated VP, Asset Lead to drive late-stage oncology drug development, from Phase 3 through regulatory submission and life cycle management.
The role is remote for US-based operations, with up to 20% travel and matrixed leadership across Clinical, Regulatory, Commercial, CMC, and Supply Chain. The ideal candidate has 12+ years in pharma/biotech, 8+ years leading cross-functional teams, and an advanced life sciences degree (MD/PhD/MBA/PharmD).

#J-18808-Ljbffr